ARTICLE | Clinical News
Oral methylnaltrexone: Phase III started
September 13, 2010 7:00 AM UTC
Progenics began a double-blind, placebo-controlled, international Phase III trial to evaluate 3 doses of oral methylnaltrexone in 700 patients. Prior to being acquired by Pfizer last October, Wyeth r...